MRK
Merck & Co Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Merck & Company Inc. (MRK) is a prominent global healthcare leader headquartered in Kenilworth, New Jersey, recognized for its innovative contributions to pharmaceuticals and vaccines aimed at improving health outcomes worldwide. Established in 1891, Merck boasts a diverse product portfolio that add...
$113.00
-1.09% ($1.24)
Volume
9.11M
52W High
$125.14
52W Low
$73.29
Market Cap
$274.03B
What to Watch This Quarter
Based on historical dataLast Quarter
-$1.28
Current Streak
6 Beats
Avg Surprise (4Q)
+7.48%
Next Earnings Report
Reports in 74 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
Apr 30, 2026
1-Day:
+2.73%
5-Day:
+3.64%
Q1 2026
Apr 23, 2026
1-Day:
-2.37%
5-Day:
-4.00%
Q4 2025
Feb 3, 2026
1-Day:
+2.15%
Q3 2025
Oct 30, 2025
1-Day:
-0.35%
5-Day:
-2.80%
Revenue & Financial Performance
Revenue Whisper
$16.48B
TWN Proprietary Estimate
Last Quarter Revenue
$16.29B
+4.3% YoY
Gross Margin
81.9%
Net Margin: -26.0%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $16.29B | +4.3% | 81.9% | -11.6% | -$4.24B |
| Q4'25 | $16.32B | +4.5% | 70.5% | 37.7% | $2.96B |
| Q3'25 | $17.18B | +3.2% | 75.6% | 43.4% | $5.79B |
| Q2'25 | $15.80B | -1.9% | 75.7% | 40.3% | $4.43B |
| Q1'25 | $15.62B | -1.0% | 75.1% | 43.0% | $5.08B |
| Q4'24 | $15.62B | +6.8% | 75.5% | 27.8% | $3.74B |
| Q3'24 | $16.66B | +4.4% | 75.5% | 23.9% | $3.16B |
| Q2'24 | $16.11B | +7.2% | 76.8% | 38.0% | $5.46B |
Company Information
Symbol
MRK
Company
Merck & Co Inc
Market Cap
$274.03B
Sector
HEALTHCARE
Next Earnings
Aug 4, 2026
Also Reporting Soon
Companies reporting earnings around the same time as MRK
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare MRK with competitors
Side-by-side earnings comparison